I. van Wijngaarden

Distribution, excretion and metabolism of neuroleptics of the butyrophenone type

W. Soudijn, I. van Wijngaarden, F. Allewijn · European Journal of Pharmacology · 1967 · 122 citations

Life Sciences, Pharmacokinetics, Pharmacology +8

Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects.

J Brugmans, D. Thienpont, I. van Wijngaarden et al. · PubMed · 1971 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +10

Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annulated indole derivatives. 1

I. van Wijngaarden, D. Hamminga, Rolf van Hes et al. · Journal of Medicinal Chemistry · 1993 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

1H-Imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists

Philip J. M. van Galen, P.J.A. Nissen, I. van Wijngaarden et al. · Journal of Medicinal Chemistry · 1991 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

5-HT_1A- versus D₂-Receptor Selectivity of Flesinoxan and Analogous<i>N</i> ⁴-Substituted<i>N</i> ¹-Arylpiperazines

Wilma Kuipers, Chris G. Kruse, I. van Wijngaarden et al. · Journal of Medicinal Chemistry · 1997 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17